Home › Funds › Patient Square Capital LP › HROW
Patient Square Capital LP position in HROW
HARROW INC · Health Care
Patient Square Capital LP reported holding 145,000 shares of HROW (HARROW INC) in its Q3 2026 13F filing — a position valued at US$4.5M, representing 0.71% of its reported portfolio and ranking #23 among its reported holdings. Patient Square Capital LP has disclosed HROW holdings in 3 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Patient Square Capital LP's HROW position evolved
Patient Square Capital LP first disclosed a stake in HROW in Q4 2025 at 7,031 shares (US$345K). The position peaked in Q1 2026 at 165,209 shares, worth US$5.8M. Across 3 filings, Patient Square Capital LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 145,000 shares valued at US$4.5M. Notable position changes include a 2250% increase in Q1 2026 (shares rose 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 7.03K | $344.52K | New |
| Q1 2026 | 165.21K | $5.83M | Add |
| Q3 2026 | 145.00K | $4.47M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HROW and 13F data
HROW (HARROW INC) is a Health Care company. 34 other funds we track also report a position in HROW — the largest reported positions include Opaleye Management Inc. (US$101.9M), Deep Track Capital, LP (US$41.2M), Divisadero Street Capital Management, LP (US$18.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HROW
- Opaleye Management Inc. 2.40M sh · $101.93M · Q2 2026
- Deep Track Capital, LP 969.00K sh · $41.15M · Q2 2026
- Divisadero Street Capital Management, LP 439.15K sh · $18.65M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 387.55K sh · $16.46M · Q2 2026
- FirstWave Capital Management LLC 211.98K sh · $9.00M · Q2 2026
- Westside Investment Management, Inc. 234.53K sh · $7.22M · Q3 2026
- Blackhawk Capital Partners, LLC 209.74K sh · $6.46M · Q3 2026
- Crawford Fund Management, LLC 142.12K sh · $6.04M · Q2 2026
- Ikarian Capital, LLC 135.78K sh · $5.77M · Q2 2026
- 12th Street Asset Management Company, LLC 163.21K sh · $5.03M · Q3 2026
More on Patient Square Capital LP
FAQ
How long has Patient Square Capital LP held HROW?
Patient Square Capital LP has disclosed HROW holdings in 3 of the last 4 reported quarters, going back to Q4 2025.
What is Patient Square Capital LP's current position in HROW?
As of Q3 2026, Patient Square Capital LP holds 145.00K shares of HROW (HARROW INC), valued at $4.47M, representing 0.71% of its reported portfolio and ranking #23.
Has Patient Square Capital LP been buying or selling HROW?
In the latest 13F filing (Q3 2026), Patient Square Capital LP newly opened its position in HROW. The position peaked in Q1 2026 at 165.21K shares.
Which other funds hold HROW?
Other major institutional holders of HROW include Opaleye Management Inc., Deep Track Capital, LP, Divisadero Street Capital Management, LP, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.